2 results
Approved WMOCompleted
To determine the maximum tolerated dose, dose limiting toxicity and recommended Phase 2 dose of BMS-753493 in subjects with advanced cancer.
Approved WMOPending
To assess the feasibility and the clinical potential of structural and functional OCT imaging with Aurisvue in patients with various middle ear problems.